![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | increases expression | ISO | Fastk (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of FASTK mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | multiple interactions | ISO | Fastk (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FASTK mRNA | CTD | PMID:17942748 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of FASTK mRNA | CTD | PMID:32145629 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:21394737 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Fastk (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FASTK mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FASTK mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fastk (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FASTK mRNA | CTD | PMID:21570461 and PMID:24680724 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of FASTK mRNA | CTD | PMID:21346803 | 2-methylcholine | affects expression | ISO | FASTK (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of FASTK mRNA | CTD | PMID:21179406 | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Fastk (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of FASTK mRNA | CTD | PMID:20188158 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Fastk (Mus musculus) | 6480464 | bis(4-hydroxyphenyl)sulfone results in decreased methylation of FASTK promoter | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FASTK mRNA | CTD | PMID:36041667 | 4-hydroxynon-2-enal | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of FASTK mRNA | CTD | PMID:12419474 | 5-fluorouracil | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Fluorouracil results in decreased expression of FASTK mRNA | CTD | PMID:34151400 | 9-cis-retinoic acid | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Alitretinoin results in decreased expression of FASTK mRNA | CTD | PMID:15982314 | acrolein | multiple interactions | ISO | FASTK (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of FASTK mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of FASTK mRNA | CTD | PMID:32699268 | acrylamide | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of FASTK mRNA | CTD | PMID:32763439 | all-trans-4-oxoretinoic acid | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | 4-oxoretinoic acid results in decreased expression of FASTK mRNA | CTD | PMID:15982314 | all-trans-retinoic acid | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Tretinoin metabolite results in decreased expression of FASTK mRNA and Tretinoin results in decreased expression of FASTK mRNA | CTD | PMID:15982314 | alpha-pinene | multiple interactions | ISO | FASTK (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of FASTK mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of FASTK mRNA | CTD | PMID:32699268 | aristolochic acid A | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of FASTK mRNA | CTD | PMID:33212167 | benzo[a]pyrene | multiple interactions | ISO | Fastk (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FASTK mRNA and AHR protein affects the reaction [Benzo(a)pyrene affects the expression of FASTK mRNA] | CTD | PMID:22228805 and PMID:27858113 | benzo[a]pyrene | affects methylation | ISO | FASTK (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of FASTK promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | FASTK (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of FASTK 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | Fastk (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of FASTK mRNA | CTD | PMID:22228805 | benzo[b]fluoranthene | multiple interactions | ISO | Fastk (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FASTK mRNA | CTD | PMID:27858113 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FASTK mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FASTK mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FASTK mRNA | CTD | PMID:30816183 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of FASTK mRNA | CTD | PMID:36041667 | bortezomib | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Bortezomib results in decreased expression of FASTK mRNA | CTD | PMID:20977926 | chlorpyrifos | increases expression | ISO | Fastk (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of FASTK mRNA | CTD | PMID:37019170 | chrysene | multiple interactions | ISO | Fastk (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FASTK mRNA | CTD | PMID:27858113 | cisplatin | increases expression | ISO | FASTK (Homo sapiens) | 6480464 | Cisplatin results in increased expression of FASTK mRNA and Cisplatin results in increased expression of FASTK protein | CTD | PMID:21278888 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of FASTK mRNA | CTD | PMID:24386269 | copper(II) sulfate | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of FASTK mRNA | CTD | PMID:19549813 | diazinon | increases methylation | ISO | FASTK (Homo sapiens) | 6480464 | Diazinon results in increased methylation of FASTK gene | CTD | PMID:22964155 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of FASTK mRNA | CTD | PMID:21266533 | ethanol | affects splicing | ISO | Fastk (Mus musculus) | 6480464 | Ethanol affects the splicing of FASTK mRNA | CTD | PMID:30319688 | fenthion | increases expression | ISO | Fastk (Mus musculus) | 6480464 | Fenthion results in increased expression of FASTK mRNA | CTD | PMID:34813904 | folic acid | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Folic Acid results in decreased expression of FASTK mRNA | CTD | PMID:21867686 | folic acid | increases expression | ISO | Fastk (Mus musculus) | 6480464 | Folic Acid results in increased expression of FASTK mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | ISO | FASTK (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of FASTK mRNA | CTD | PMID:18045764 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of FASTK gene and furan results in increased methylation of FASTK promoter | CTD | PMID:22079235 | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of FASTK mRNA | CTD | PMID:24136188 | hydroxytyrosol | increases expression | ISO | FASTK (Homo sapiens) | 6480464 | 3 and 4-dihydroxyphenylethanol results in increased expression of FASTK mRNA | CTD | PMID:12482581 | hypochlorous acid | decreases expression | ISO | Fastk (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of FASTK mRNA | CTD | PMID:19376150 | isotretinoin | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of FASTK mRNA | CTD | PMID:15982314 | methidathion | increases expression | ISO | Fastk (Mus musculus) | 6480464 | methidathion results in increased expression of FASTK mRNA | CTD | PMID:34813904 | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of FASTK mRNA | CTD | PMID:22124623 | ozone | multiple interactions | ISO | FASTK (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of FASTK mRNA more ... | CTD | PMID:32699268 and PMID:35430440 | p-menthan-3-ol | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Menthol results in decreased expression of FASTK mRNA | CTD | PMID:26760959 | paracetamol | affects expression | ISO | Fastk (Mus musculus) | 6480464 | Acetaminophen affects the expression of FASTK mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FASTK mRNA | CTD | PMID:33387578 | perfluorohexanesulfonic acid | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of FASTK mRNA | CTD | PMID:25812627 | perfluorononanoic acid | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of FASTK mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of FASTK mRNA | CTD | PMID:25812627 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fastk (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of FASTK mRNA | CTD | PMID:36331819 | perfluorooctanoic acid | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of FASTK mRNA | CTD | PMID:25812627 | resveratrol | multiple interactions | ISO | FASTK (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of FASTK mRNA | CTD | PMID:23557933 | silver atom | increases expression | ISO | Fastk (Mus musculus) | 6480464 | Silver results in increased expression of FASTK mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | Fastk (Mus musculus) | 6480464 | Silver results in increased expression of FASTK mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of FASTK mRNA | CTD | PMID:12760830 | sunitinib | increases expression | ISO | FASTK (Homo sapiens) | 6480464 | Sunitinib results in increased expression of FASTK mRNA | CTD | PMID:31533062 | temozolomide | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of FASTK mRNA | CTD | PMID:31758290 | tert-butyl hydroperoxide | decreases expression | ISO | FASTK (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of FASTK mRNA | CTD | PMID:12419474 and PMID:15336504 | testosterone | increases expression | ISO | FASTK (Homo sapiens) | 6480464 | Testosterone results in increased expression of FASTK mRNA | CTD | PMID:33359661 | testosterone enanthate | affects expression | ISO | FASTK (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of FASTK mRNA | CTD | PMID:17440010 | tetrachloroethene | decreases expression | ISO | Fastk (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of FASTK mRNA | CTD | PMID:28973375 | tetraphene | increases expression | ISO | Fastk (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of FASTK mRNA | CTD | PMID:26377693 | tetraphene | multiple interactions | ISO | Fastk (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of FASTK mRNA | CTD | PMID:27858113 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of FASTK mRNA | CTD | PMID:34492290 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of FASTK mRNA | CTD | PMID:33387578 | triptonide | affects expression | ISO | Fastk (Mus musculus) | 6480464 | triptonide affects the expression of FASTK mRNA | CTD | PMID:33045310 | valproic acid | affects expression | ISO | Fastk (Mus musculus) | 6480464 | Valproic Acid affects the expression of FASTK mRNA | CTD | PMID:17963808 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of FASTK mRNA | CTD | PMID:23034163 | |